Concise Review: Markers for Assessing Human Stem Cell-Derived Implants as {beta}-Cell Replacement in Type 1 Diabetes

This study proposes the combined use of in vitro, in vivo, and ex vivo markers to assess this potential in preclinical models and in clinical studies.

Source: Stem Cells Translational Medicine - September 20, 2016 Category: Stem Cells Authors: Pipeleers, D., Robert, T., De Mesmaeker, I., Ling, Z. Tags: Embryonic Stem Cells, Pluripotent Stem Cells, Pancreas, Enabling Technologies for Cell-Based Clinical Translation Source Type: research